Nxera Pharma reports Q4 results
Source: SeekingAlpha
2026-02-13 12:24:33 ET
More on Nxera Pharma
- Nxera Pharma Co., Ltd. (SOLTF) Q4 2025 Earnings Call Transcript
- Nxera Pharma Co., Ltd. (SOLTF) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Nxera Pharma Co., Ltd. (SOLTF) Discusses R&D Restructuring, Pipeline Prioritization, and Focus on Obesity and Metabolism - Slideshow
- Seeking Alpha’s Quant Rating on Nxera Pharma
- Historical earnings data for Nxera Pharma
Read the full article on Seeking Alpha
For further details see:
Nxera Pharma reports Q4 results
Nxera Pharma Co Ltd Ord
NASDAQ: SOLTF
SOLTF Trading
-74.1% G/L:
$5.44 Last:
100 Volume:
$5.44 Open:
SOLTF Latest News
March 05, 2026 03:03:06 am
Nxera Pharma to Receive US$3 Million Milestone Payment from Centessa Pharmaceuticals
March 04, 2026 03:54:17 am
Nxera Pharma Submits Marketing Authorization Application for Daridorexant in South Korea
February 13, 2026 01:36:46 am
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2025
February 12, 2026 03:45:00 am
Nxera Pharma to Receive $1.8 Million Milestone Payment from Centessa Pharmaceuticals
